Aurinia Pharmaceuticals, Inc. (AUPH)
15.87
+0.21
(+1.34%)
USD |
NASDAQ |
Jun 09, 14:12
Aurinia Pharmaceuticals EPS Diluted (Quarterly) : 0.2496 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| enGene Therapeutics, Inc. | -0.4423 |
| Medicus Pharma Ltd. | -0.2231 |
| Kiniksa Pharmaceuticals International Plc | 0.2741 |
| Xenon Pharmaceuticals, Inc. | -1.171 |
| Psyence Biomedical Ltd. | 0.00 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 34.36M |
| Revenue (Quarterly) | 77.70M |
| Total Expenses (Quarterly) | 43.35M |
| Enterprise Value | 1.738B |
| Gross Profit Margin (Quarterly) | 91.63% |
| Profit Margin (Quarterly) | 44.21% |
| Earnings Yield | 13.63% |
| Operating Earnings Yield | 5.96% |
| Normalized Earnings Yield | 13.64 |